Answer
Reboxetine selectively and potently inhibits noradrenaline reuptake, increasing its availability in the synaptic cleft, with only a weak effect on serotonin (5-HT) reuptake and no effect on dopamine uptake.
Sources for this answer
- Edronax 4mg TabletsPfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 27Document updated
Sources checked